首页 | 本学科首页   官方微博 | 高级检索  
     

GemOX方案治疗老年复发难治性非霍奇金淋巴瘤疗效观察
引用本文:陈希,田思源,魏金芝,丛智荣. GemOX方案治疗老年复发难治性非霍奇金淋巴瘤疗效观察[J]. 肿瘤基础与临床, 2011, 24(5): 395-396
作者姓名:陈希  田思源  魏金芝  丛智荣
作者单位:南通市肿瘤医院肿瘤内科,江苏南通,226361
摘    要:目的 探讨吉西他滨联合奥沙利铂(GemOX方案)治疗老年复发难治性非霍奇金淋巴瘤(NHL)的疗效和毒副反应.方法全组30例患者均接受GemOX方案化疗:吉西他滨1000 mg/m2,d1.8,静脉滴注;奥沙利铂130 mg/m2,d1,静脉滴注.每21 ~28 d为1个周期,完成2个周期化疗后评价疗效,完成1个周期化疗...

关 键 词:非霍奇金淋巴瘤  二线化疗  吉西他滨  奥沙利铂

The Efficacy of GemOX Regimen in the Treatment of the Elderly Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
Chen Xi,Tian Siyuan,Wei Jinzhi,Cong Zhirong. The Efficacy of GemOX Regimen in the Treatment of the Elderly Patients with Relapsed or Refractory Non-Hodgkin Lymphoma[J]. journal of basic and clinical oncology, 2011, 24(5): 395-396
Authors:Chen Xi  Tian Siyuan  Wei Jinzhi  Cong Zhirong
Affiliation:(Department of Oncology,Nantong Tumor Hospital,Nantong 226361,China)
Abstract:Objective To evaluate the efficacy and toxicities of gemcitabine combined with oxaliplatin(GemOX) regimen in the treatment of the elderly patients with relapsed or refractory non-Hodgkin lymphoma(NHL).Methods All the 30 patients received GemOX regimen chemotherapy: gemcitabine 1 000 mg/m2,d1,8,ivgtt;oxaliplatin 130 mg/m2,d1,ivgtt.Every 21-28 days were 1 cycle.The efficacy was evaluated after 1 cycle of chemotherapy.The toxicities were evaluated after 1 cycle of chemotherapy.Results Of all the 30 cases,the overall response rate was 70.0%.The main toxicities were marrow suppression and gastrointestinal reaction.Conclusion GemOX regimen is effective and safe for the elderly patients with relapsed or refractory NHL.
Keywords:non-Hodgkin lymphoma  second-line chemotherapy  gemcitabine  oxaliplatin
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号